MALDI-TOF Mass Spectrometric Analysis of Brain Tumor Cyst Fluid Reveals a Protein Peak Corresponding to ApoC1 and LuzP6

Journals Menu

Follow SCIRP

ISSN Print: 2163-0569
ISSN Online: 2163-0585
www.scirp.org/journal/ojmn
E-mail: ojmn@scirp.com

Citations h5-index & Ranking*

"MALDI-TOF Mass Spectrometric Analysis of Brain Tumor Cyst Fluid Reveals a Protein Peak Corresponding to ApoC1 and LuzP6"
written by Mathias Groll, Jochen Frenzel, Matthias Krause, Anne Schänzer, Wolf Müller, Klaus Eschrich, Ulf Nestler,
published by Open Journal of Modern Neurosurgery, Vol.8 No.3, 2018

has been cited by the following article(s):

[1]	Feasibility of ApoC1 serum levels as tumor biomarker in glioblastoma patients: a pilot study
	Scientific Reports, 2022

[2]	The mean ApoC1 serum level in postoperative samples from neurosurgical patients is lower than in preoperative samples and during chemotherapy
	Biology, 2022

[3]	Assessment of ApoC1, LuzP6, C12orf75 and OCC-1 in cystic glioblastoma using MALDI–TOF mass spectrometry, immunohistochemistry and qRT-PCR
	Medical molecular morphology, 2019

[4]	Familial glioblastoma clustering in adult patients: a case report of two non-twin siblings and review of the literature
	International medical case reports journal, 2019

[1]	The Mean ApoC1 Serum Level in Postoperative Samples from Neurosurgical Patients Is Lower than in Preoperative Samples and during Chemotherapy Biology, 2022 DOI:10.3390/biology11071021

[2]	Feasibility of ApoC1 serum levels as tumor biomarker in glioblastoma patients: a pilot study Scientific Reports, 2022 DOI:10.1038/s41598-022-21216-1

[3]	Assessment of ApoC1, LuzP6, C12orf75 and OCC-1 in cystic glioblastoma using MALDI–TOF mass spectrometry, immunohistochemistry and qRT-PCR Medical Molecular Morphology, 2019 DOI:10.1007/s00795-019-00223-8

Follow SCIRP